Latest stories on LRMR
Wedbush reiterates Larimar Therapeutics stock rating at Outperform
Investing.com Analyst Ratings58 · neutralanalyst
Larimar Therapeutics, Inc. (LRMR) files 8-K
SEC 8-K50 · neutralgeneral
Larimar Therapeutics Completes Rolling BLA Submission Seeking Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Business Insider64 · neutralproduct/pr
Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
GlobeNewswire53 · neutralproduct/pr
3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
MarketBeat67 · bullishanalyst
Larimar Therapeutics appoints John Harlow as COO
The Fly56 · neutralgeneral
Larimar Therapeutics, Inc. (LRMR) files 8-K
SEC 8-K50 · neutralgeneral
Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Business Insider56 · neutralgeneral
Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
GlobeNewswire56 · neutralgeneral
Larimar Therapeutics assumed with an Outperform at Leerink
The Fly61 · neutralanalyst
Larimar Therapeutics GAAP EPS of -$0.30 beats by $0.09
Seeking Alpha58 · neutralearnings
Larimar Therapeutics, Inc. (LRMR) files 8-K
SEC 8-K50 · neutralgeneral
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Business Insider59 · neutralgeneral
LRMR Options Prices for Larimar Therapeutics Stock
Barchart50 · neutralgeneral
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Yahoo Finance67 · bullishproduct/pr
LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000
Stocktwits News56 · neutralgeneral
Here’s What Citi Thinks About Larimar Therapeutics (LRMR)
Yahoo Top61 · neutralanalyst
LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns
Stocktwits News58 · neutralanalyst
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia - Slideshow
Seeking Alpha65 · bullishproduct/pr
Larimar Therapeutics: Late-Stage FA Program Advances Amid Execution Risks
Seeking Alpha58 · neutralproduct/pr
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia Transcript
Seeking Alpha63 · neutralproduct/pr
Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know
Stocktwits News67 · bullishproduct/pr
Larimar Advances Nomlabofusp BLA Toward Accelerated Approval
TipRanks73 · bullishproduct/pr